Letko, Brosseau & Associates Inc Myovant Sciences Ltd. Transaction History

Letko, Brosseau & Associates Inc

  • $5.37 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021
BUY
$13.8 - $27.62 $182,215 - $364,694
13,204 Added 26.41%
63,204 $1.75 Million
Q3 2020

Nov 09, 2020
SELL
$14.05 - $22.6 $21,075 - $33,900
-1,500 Reduced 2.91%
50,000 $703,000
Q2 2020

Aug 07, 2020
BUY
$7.34 - $20.84 $378,010 - $1.07 Million
51,500 New
51,500 $1.06 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email